INTRODUCTION
Fluoroquinolones comprise a series of broadspectrum synthetic antibacterial agents derived from nalidixic acid. They were discovered casually in 1962 and since then are essentially used in the treatment of several infectious diseases (Bertino and Fish, 2000; Fierens, Hillaert and Van Den Bossche, 2000; Marzo and Dal Bo, 2002; Arteseros et al., 2002) .
Ciprofloxacin (CIP) and norfloxacin (NOR) are quinolones with fluorine at position 6 of naphthyridine ring. The chemical structures of fluoroquinolones are shown in Figure 1 . Published structure-activity data shows that fluorine atom help broadens their activity spectrum against both gram-negative and gram-positive pathogens (Lorian, 1996; Bertino, Fish, 2000; Fierens, Hillaert and Van Den Bossche, 2000; Arteseros et al., 2002; Samanidou, Demetriou, Papadoyannis, 2003) .
The primary target of fluoroquinolones is bacterial enzyme DNA gyrase or topoisomerase II (Mandel, Petri Júnior, 1996; Bertino, Fish, 2000; Marzo, Dal Bo, 2000; Arteseros et al., 2002) . They are generally well tolerated, safe and adverse effects vary significantly depending on their physicochemical properties (Mandel, Petri Júnior, 1996; Bertino, Fish, 2000) . Majority of them are well absorbed through oral route and have a long half-life, being widely distributed within body tissues and fluids (Marzo, Dal Bo, 2002; Samanidou, Demetriou, Papadoyannis, 2003) .
Due to the minor structural differences amongst members of the same group, it is difficult to identify and to determine their respective degradation products (Joshi, 2002) . Several analytical methods for quantitative determination of fluoroquinolones in pharmaceutical formulations are described in scientific literature, like capillary electrophoresis (Bhowal, Das, 1991; Flurer, 1997; Sun, Chen, 1997) , UV spectrophotometry (Fratini, Schapoval, 1996; Chowdary, Rao, 1997) , titrimetry (Belal, Al-Majed, Al-Obaid, 1999) , and high performance liquid chromatography (HPLC) (United States Pharmacopeia , 2004; British Pharmacopoeia, 1999; Mazuel, 1991) , amongst others.
HPLC is widely employed for the determination of CIP and NOR either in biological fluids, edible animal products, feed and pharmaceutical formulations (Barbosa, Berges, Sanz-Nebot, 1996; Belal, Al-Majed, Al-Obaid, 1999; Budvari-Barany et al. 1991; Córdoba-Borrego, Cordoba-Diaz, Cordoba-Diaz, 1999; Husain et al. 1995; Kirkland, Mccombs, Kirkland, 1994; Lacroix, Curran, Sears, 1996; Morley, Erold, 1993; Samanidou, Christodoulou, Papadoyannis, 2005; Sowinski, Kays, 2004; Thoppil, Amin, 2000; Tiefenbacher et al. 1994; Torniainen, Tammilehto, Ulvi, 1996; Vybiralova et al. 2005) .
Majority of these HPLC methods were applied in determination of fluoroquinolones in biological fluids, edible animal products, feeds and to a lesser extent in pharmaceutical formulations. Most of the reported methods involve troublesome mobile phase (buffers) and difficult sample preparation. The objective of this research was to develop and validate an efficient HPLC method for quantitative determination of second-generation quinolones in pharmaceutical preparations. A rapid, accurate and sensitivity method was developed for quantitative determination of two fluoroquinolones: CIP and NOR in tablets and injectable preparations.
EXPERIMENTAL Material

Reagents and chemicals
All solvents were of HPLC grade and reagents were analytical grade. Acetonitrile and phosphoric acid were obtained from Merck The active pharmaceutical ingredients (API) including CIP (99.5%) and NOR (100.1%) were kindly donated by a local pharmaceutical industries and were used as reference standards without further purification.
Samples
The samples used in this research are presented in Table 1 . 
B. Column
The analytical column was a reversed phase LiChrospher ® 100 RP-18 (125 x 4 mm, 5 µm) in LichroCART ® -Merck.
Methods
Chromatographic conditions
All analyses were done at ambient temperature (24 ± 2 ºC) under isocratic conditions. The mobile phase consisted of a volumetric mixture of water:acetonitrile:triethylamine (80:20:0.3 v/v/v). The pH of final mixture was adjusted to 3.3 with phosphoric acid. The flow rate was 1.0 mL/min and volume of injection was 20 µL. All solutions, including mobile phase, were sonicated during 25 min before use. The UV detection was made at 279 nm.
Standard solutions preparation
Accurately weighed amount of standards of CIP and NOR, equivalent to 20.0 mg of freebase were transferred to 100 mL volumetric flasks, separately. The volume was completed with mobile phase and methanol, in case of CIP and NOR, respectively. The resulting solutions were sonicated during 25 min and filtered through a filtration membrane. Final concentrations were 200.0 µg/mL. Aliquots of each solution were accordingly diluted with mobile phase in order to obtain solutions with final concentration of 50.0 µg/mL.
Calibration curves
Six different concentration levels (4.0, 8.0, 12.0, 16.0, 20.0 and 24.0 µg/mL) were obtained of each standard solution, conveniently diluted with mobile phase. Each solution was injected in the chromatographic system (n = 3) and mean values of peak areas were plotted against concentrations. The curves were adjusted by linear regression with least mean square method (Harris, 2001; Leite, 2002) .
Linearity
The linearity of the proposed method was evaluated by using calibration curves to calculate coefficient of correlation and intercept values.
Sample preparation
Tablets
Twenty tablets of each sample were individually weighed and triturated to obtain homogeneous mixture. An amount of powder equivalent to 100.0 mg of freebase, was transferred to a 100 mL volumetric flask. The volume was completed with mobile phase for CIP, while for NOR, methanol was used. The resulting solutions were sonicated during 25 min to facilitate proper solubilization. All the solutions were filtered through Whatman filter paper nº 1 Aliquots of each filtered solution were accordingly diluted, with mobile phase, in order to obtain solutions with final concentration of 50.0 µg/mL. Assays were performed after appropriate dilutions of above solution.
Injectable preparations
For injectable sample, 5.0 mL of the solution was accurately measured and the procedure adopted for sample preparation was similar to that described for tablets. Appropriate dilutions were made with mobile phase to final solutions containing 50.0 µg/mL of the drug in freebase. Assays were performed after appropriate dilutions of above solution.
Specificity
The specificity of proposed method was evaluated by comparing the results obtained by analysis of placebo formulations using the proposed method.
Accuracy
To evaluate the accuracy of the proposed method, recovery tests were carried out with all samples. Recovery tests were performed by adding known amounts of standard solutions to sample followed by analysis using the proposed method. Aliquots of standard and samples solutions were transferred to 25 mL volumetric flasks and final volumes were completed with mobile phase. The percentage of recovery (R%) was calculated as indicated by Association of Official Analytical Chemists International (2002).
Precision
The precision of proposed method was evaluated through intra-day repeatability of responses after replicate (n = 10) injection of sample solutions (5.0 µg/mL). The precision is expressed as RSD amongst responses.
Robustness
The robustness of the proposed method was evaluated by intentional minor modifications in the composition of the mobile phase as well as its pH. The modified mobile phase was used to analyze drug samples (Chromatograms not shown).
Detection limit (DL) and quantification limit (QL)
The DL and QL were calculated through following equations: 
RESULTS AND DISCUSSION
In order to validate an efficient method for analysis of drugs in pharmaceutical formulations, preliminary tests were performed with the objective to select adequate and optimum conditions. Parameters such as detection wavelength, ideal mobile phase and their proportions, optimum pH and concentration of the standard solutions were exhaustively studied.
Several binary or ternary eluents were tested using different proportions of solvents such as acetonitrile, methanol and water. Some ion-pair reagents were also studied. A flow rate of 1.0mL/min was selected after preliminary tests.
The proposed method is simple and do not involve laborious time-consuming sample preparation. The method was statistically validated for their accuracy and precision. The chromatograms of sample containing CIP and NOR can be observed in Figure 2 (a -b) and 2c, respectively. As could be seen, excipients did not interfere in the analysis of CIP and NOR using proposed method.
The calibration curves showed linearity over a concentration range from 4.0 to 24.0 µg/mL. The correlation coefficients obtain with linear regression of curve were better than 0.9999. Linearity data shows concentration interval of studied fluoroquinolones in which the intensity of the detector response is proportional to the concentration of the analyzed substance. The DL and QL of CIP and NOR were 0.16, 0.50 and 0.28, 0.86 µg/mL, respectively. Table 2 shows the statistical parameters of CIP and NOR analyzed by the proposed method.
The standard deviation amongst replicate responses and relative standard deviation values (RSD) were less than 1.0%, indicating precision of the method. The statistical data results obtained in the analysis of commercially available samples are shown in Table 3 . The recovery values obtained were between 97.92 and 103.95%, confirming accuracy of the proposed method. The percentage of recovery results are presented in Table 4 . There was minor delay in the retention time when pH of the mobile phase varies in 0.5 units. Practically no effect was observed when mobile phase components were intentionally deviated. Changes as much as 5 mL of each component in the mobile phase were altered. Consequently, due to this observation, the robustness of the method can be confirmed.
CONCLUSION
The proposed HPLC method enables quantitative determination of second generation quinolones such as CIP and NOR in pharmaceutical formulations. UV detection at 279 nm was found to be suitable without any interference from tablets or injectable solution excipients or solvents. The calibration curves were found to be linear with correlation coefficients above 0.9999. The relative standard deviations values were less than 1.0%. Analytical results of samples were in accordance with those of standard solution in the same concentrations. Preparation of samples is easy and efficient. The proposed HPLC method is fast, precise, accurate, sensitive, and efficient and can be used in routine analysis in quality control laboratories.
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RESUMO
